EFSCE
LGND icon

Enterprise Financial Services Corp (EFSC)’s Ligand Pharmaceuticals LGND Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21
Closed -$2K – 839
2021
Q2 		$2K Hold
21
– – ﹤0.01% 1142
2021
Q1 		$2K Hold
21
– – ﹤0.01% 1151
2020
Q4 		$1K Hold
21
– – ﹤0.01% 1215
2020
Q3 		$1K Hold
21
– – ﹤0.01% 1190
2020
Q2 		$1K Buy
21
+3
+17% +$190 ﹤0.01% 1198
2020
Q1 		$1K Buy
+18
New +$1.02K ﹤0.01% 1172
2016
Q4 		– Sell
-87
Closed -$6K – 1078
2016
Q3 		$6K Hold
87
– – ﹤0.01% 699
2016
Q2 		$6K Hold
87
– – ﹤0.01% 673
2016
Q1 		$6K Buy
+87
New +$5.29K ﹤0.01% 669

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s LGND Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 21 shares — an estimated $2K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in LGND in Q1 2016 and held it in 9 quarters. The position peaked at $6K in Q3 2016. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 21 Ligand Pharmaceuticals shares in Q3 2021, an estimated $2K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Ligand Pharmaceuticals in Q1 2016 and held it in 9 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Ligand Pharmaceuticals position peaked at $6K in Q3 2016.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.